G9764 – Patient has been treated with a systemic medication for psoriasis vulgaris
HCPCS Level II code · G codes: Procedures / Professional Services (Temporary)
HCPCS codeG9764
- Long description
- Patient has been treated with a systemic medication for psoriasis vulgaris
- Short description
- Pt treatd w/oral syst or bio
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
Z2Undefined codes- Added
- January 1, 2017
- Last change
- January 1, 2019 – No change
Frequently asked questions
What is HCPCS code G9764?
G9764 is a HCPCS Level II code for patient has been treated with a systemic medication for psoriasis vulgaris.
Does Medicare cover G9764?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby G codes
- G9756 – Surgical procedures that included the use of silicone oil
- G9757 – Surgical procedures that included the use of silicone oil
- G9758 – Patient in hospice at any time during the measurement period
- G9759 – History of preoperative posterior capsule rupture
- G9760 – Patients who use hospice services any time during the measurement period
- G9761 – Patients who use hospice services any time during the measurement period
- G9762 – Patient had at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays
- G9763 – Patient did not have at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays
- G9765 – Documentation that the patient declined change in medication or alternative therapies were unavailable, has documented contraindications, or has not been treated with a systemic medication for at least six consecutive months (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi
- G9766 – Patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment
- G9767 – Hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment
- G9768 – Patients who utilize hospice services any time during the measurement period
- G9769 – Patient had a bone mineral density test in the past two years or received osteoporosis medication or therapy in the past 12 months
- G9770 – Peripheral nerve block (pnb)
- G9771 – At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) achieved within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time
- G9772 – Documentation of medical reason(s) for not achieving at least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time (e.g., emergency cases, intentional hypothermia, etc.)
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.